SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech & Nutrition informs about disclosure

18 Sep 2023 Evaluate

In compliance with the provision of SEBI Reg 2011, Emmessar Biotech & Nutrition has informed that Mathurakavi Srinivasa Raghavan Ayyangar, Chief Promoters, have acquired 4765 equity shares of the company from September 01 to September 15, 2023, Through open market.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

26.29 -0.70 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×